Danazol and Myelodysplasic Syndromes
letter
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
This letter reports on one patient with myelodysplastic syndrome and severe thrombocytopenia who responded positively to danazol treatment, similar to previously published cases.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Letters and Corrections1 March 1986Danazol and Myelodysplasic SyndromesABRAHAM KORNBERG, M.D., RIVKA YONA, M.D., SANDA IUKLEA, M.D., SUZANA KAUFMAN, M.D.ABRAHAM KORNBERG, M.D.Search for more papers by this author, RIVKA YONA, M.D.Search for more papers by this author, SANDA IUKLEA, M.D.Search for more papers by this author, SUZANA KAUFMAN, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-104-3-445_3 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: The successful treatment with danazol of three patients with myelodysplastic syndromes and severe thrombocytopenia was described recently by Cines and coworkers (1). After administration of danazol, the platelet count of each patient rose and clinical bleeding stopped. We have had a similar experience with one patient.During 1985 we treated seven patients with myelodysplastic syndromes with danazol, 600 mg/d, for 2 to 4 months. Hemoglobin levels were 5 to 10.1 g/dL, leukocyte counts were 1500 to 6400/mm3, and platelet counts were 14 000 to 132 000/mm3. Previous treatment with oxymetholone, nandrolone phenpropionate, folic acid, pyridoxine phosphate, and...Reference1. CINESCASSILETHKISS DPJ. Danazol therapy in myelodysplasia. Ann Intern Med. 1985;103:58-60. LinkGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: "Assaf Harofeh" Medical Center Zerifin, Beer-Yakov 70300 Israel PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDanazol for the treatment of thrombocytopenia in patients with myelodysplastic syndromeTherapeutic efficacy of danazol in myelodysplastic syndromesDanazol and Erythema MultiformeLeonard E. Gately III, MD, W. Abe Andes, MDDanazol in the treatment of myelodysplastic syndromes 1 March 1986Volume 104, Issue 3Page: 445-446KeywordsFolic acidHemoglobinHemorrhageMyelodysplastic syndromesPhosphatesPlateletsPyridoxine Issue Published: 1 March 1986 PDF downloadLoading ...
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (3)
References (1)
- doi:10.7326/0003-4819-103-1-58 via openalex
Cited by (3)
Source provenance
- openalex
- last seen: 2026-05-10T11:25:47.971343+00:00
License: CC0
· commercial use OK